These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11487211

  • 1. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
    Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, Colao AM, Filla A.
    Neurol Sci; 2001 Feb; 22(1):79-80. PubMed ID: 11487211
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 3. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
    Pellecchia MT, Pivonello R, Colao A, Barone P.
    Clin Med Res; 2006 Dec 28; 4(4):322-5. PubMed ID: 17210980
    [Abstract] [Full Text] [Related]

  • 5. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
    Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M.
    J Neurol; 2020 Mar 28; 267(3):855-859. PubMed ID: 32034477
    [Abstract] [Full Text] [Related]

  • 6. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 28; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 7. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K, Zeng Y, Song C, Fu Y, Wan Q.
    J Neurol; 2010 Sep 28; 257(9):1486-91. PubMed ID: 20405138
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of Parkinson's disease: a new blood test?
    Hiner BC.
    Clin Med Res; 2006 Dec 28; 4(4):246-7. PubMed ID: 17210972
    [No Abstract] [Full Text] [Related]

  • 9. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ, Hermann KL, Schmahmann JD.
    Cerebellum; 2016 Dec 28; 15(6):663-679. PubMed ID: 26467153
    [Abstract] [Full Text] [Related]

  • 10. Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Mathias CJ, Kimber J, Watson L, Muthane U.
    J Neurol; 2002 Apr 28; 249(4):488-9. PubMed ID: 11967661
    [No Abstract] [Full Text] [Related]

  • 11. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy.
    Gardner RC, Schmahmann JD.
    Ann Neurol; 2010 Mar 28; 67(3):404-8. PubMed ID: 20373353
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone response to growth hormone-releasing hormone (GHRH), insulin, clonidine and arginine after GHRH pretreatment in obese children: evidence of somatostatin increase?
    Volta C, Bernasconi S, Iughetti L, Ghizzoni L, Rossi M, Costa M, Cozzini A.
    Eur J Endocrinol; 1995 Jun 28; 132(6):716-21. PubMed ID: 7788012
    [Abstract] [Full Text] [Related]

  • 13. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov 28; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure.
    Young TM, Asahina M, Watson L, Mathias CJ.
    Mov Disord; 2006 May 28; 21(5):609-15. PubMed ID: 16404729
    [Abstract] [Full Text] [Related]

  • 15. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P.
    Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703
    [Abstract] [Full Text] [Related]

  • 16. Serum prolactin levels in Parkinson's disease and multiple system atrophy.
    Winkler AS, Landau S, Chaudhuri KR.
    Clin Auton Res; 2002 Oct 30; 12(5):393-8. PubMed ID: 12420085
    [Abstract] [Full Text] [Related]

  • 17. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P.
    Ann Neurol; 2006 Nov 30; 60(5):611-615. PubMed ID: 16958123
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW.
    J Neurol; 2002 Sep 30; 249(9):1206-10. PubMed ID: 12242540
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM, Mönig H, Mill G, Gödde E, Schulte HM.
    Exp Clin Endocrinol Diabetes; 1995 Sep 30; 103(3):205-8. PubMed ID: 7584524
    [Abstract] [Full Text] [Related]

  • 20. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec 30; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.